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Multilineage  hematopoiesis  depends  on  rare 
multipotent BM-resident hematopoietic stem 
cells (HSCs; Orkin and Zon, 2008). HSCs pos-
sess multiple cell fate choices: they can remain 
quiescent, self-renew, undergo apoptosis, or dif-
ferentiate into blood lineages. Strict regulation 
of these fates is critical for HSC maintenance, 
and dysregulation of the balance between these 
fates is a common feature of blood malignan-
cies (Lobo et al., 2007). Because of their unique 
ability to sustain life-long multilineage hemato-
poiesis, HSCs rely on mechanisms safeguarding 
their integrity and protecting them from ac-
quiring mutations, which could lead to their 
malignant transformation. Although HSC qui-
escence has been proposed to play protective 
functions  against  stem  cell  exhaustion  and 
against the acquisition of mutations leading to 
malignant  transformation  (Lobo  et  al.,  2007; 
Orford and Scadden, 2008), the role of autoph-
agy in these processes remains unknown.
Autophagy is a catabolic pathway charac-
terized by the formation of a double-membrane 
vesicle, called the autophagosome, which en-
gulfs cytoplasmic components and delivers them 
to lysosomes for degradation (Klionsky, 2007). 
The pathway is highly conserved in eukaryotes 
and is regulated both developmentally and by 
environmental factors such as nutrient/energy 
availability, hypoxia, and reactive oxygen species 
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The role of autophagy, a lysosomal degradation pathway which prevents cellular damage,  
in the maintenance of adult mouse hematopoietic stem cells (HSCs) remains unknown.  
Although normal HSCs sustain life-long hematopoiesis, malignant transformation of HSCs 
leads to leukemia. Therefore, mechanisms protecting HSCs from cellular damage are essen-
tial to prevent hematopoietic malignancies. In this study, we crippled autophagy in HSCs by 
conditionally deleting the essential autophagy gene Atg7 in the hematopoietic system. This 
resulted in the loss of normal HSC functions, a severe myeloproliferation, and death of the 
mice within weeks. The hematopoietic stem and progenitor cell compartment displayed an 
accumulation of mitochondria and reactive oxygen species, as well as increased prolifera-
tion and DNA damage. HSCs within the LinSca-1+c-Kit+ (LSK) compartment were signifi-
cantly reduced. Although the overall LSK compartment was expanded, Atg7-deficient LSK 
cells failed to reconstitute the hematopoietic system of lethally irradiated mice. Consistent 
with loss of HSC functions, the production of both lymphoid and myeloid progenitors was 
impaired in the absence of Atg7. Collectively, these data show that Atg7 is an essential 
regulator of adult HSC maintenance.
©  2011  Mortensen  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
six  months  after  the  publication  date  (see  http://www.rupress.org/terms).   
After six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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Figure 1.  HSCs from Vav-Atg7/ BM fail to reconstitute the hematopoietic system of lethally irradiated mice. (A) Relative Atg7 messenger 
RNA (mRNA) expression in murine long-term HSCs (LT-HSCs), short-term HSCs (ST-HSCs), and LMPPs was measured by real-time Q-PCR. Data are mean ± 
SEM (n = 3). (B) CFC assay performed on total BM cells from WT (Vav-iCre+; Atg7Flox/WT or Vav-iCre; Atg7Flox/Flox) and Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox) 
mice. The graph shows the mean number of CFC colonies ± SD counted on day 12 (n = 3). (C) The methylcellulose cultures shown in B were replated in 
methylcellulose 12 d after initial plating. The total number of colonies was counted after 10 d in culture. Mean values ± SD (n = 3) are shown. (D) Competitive JEM VOL. 208, March 14, 2011 
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Vav-Atg7/ mice. However, although anemia was still ob-
served when the deletion of Atg7 was restricted to the ery-
throid lineage, it was milder and nonprogressive (Mortensen 
and Simon, 2010; Mortensen et al., 2010a). The phenotypic 
difference between pan-hematopoietic and erythroid knock-
outs of Atg7 was partly caused by the less efficient excision 
driven by the erythroid-specific ErGFP-Cre line (Heinrich   
et al., 2004) when compared with  Vav-iCre (Mortensen et al., 
2010a). However, this provided an incomplete explanation for 
the different phenotypes observed. Importantly, the erythropoi-
etin receptor promoter that drives Cre expression in ErGFP-
Cre mice is active only in erythroid progenitors (Heinrich   
et al., 2004), whereas the Vav gene regulatory elements (used 
to drive the expression of iCre in Vav-iCre mice) are active in 
all nucleated hematopoietic cells (Ogilvy et al., 1998, 1999b), 
including HSCs (Ogilvy et al., 1999a; de Boer et al., 2003). 
We therefore investigated the role of Atg7 in the maintenance 
of hematopoietic stem and progenitor cells (HSPCs).
Atg7 is essential for HSC activity
Atg7 expression analysis showed that it is uniformly expressed 
in long-term HSCs (defined as LinSca-1+c-Kit+ [LSK] 
CD34Flt3), short-term HSCs (LSK CD34+Flt3), and 
lymphoid-primed multipotent progenitors (LMPPs; LSK 
CD34+Flt3+; Fig. 1 A). To investigate a functional require-
ment for Atg7 in adult hematopoiesis, we analyzed Vav-
Atg7/ mice. We confirmed excision of Atg7 in sorted 
Vav-Atg7/ BM lineage-negative cells enriched in HSPCs 
(Fig. S1 A). The role of Atg7 in the activity of HSPCs was first 
addressed by performing colony-forming cell (CFC) assays, in 
which BM cells from Vav-Atg7/ mice generated a similar 
number of colonies compared with BM cells from WT litter-
mates but failed to efficiently form secondary colonies after 
replating (Fig. 1, B and C).
Next, we performed competitive and noncompetitive in 
vivo repopulation assays to examine the reconstitution capac-
ity of Atg7/ BM cells. In competitive repopulation assays, 
Vav-Atg7/ or WT BM cells (CD45.2+) were mixed in a 1:1 
ratio with CD45.1+ WT BM and transplanted into CD45.1+ 
lethally irradiated hosts. As Vav-Atg7/ mice begin to develop 
(ROS; Scherz-Shouval and Elazar, 2007). Formation of the 
autophagosome requires two ubiquitin-like conjugation sys-
tems, in which Atg12 (autophagy-related gene 12) is covalently 
linked to Atg5, and Atg8 is conjugated to phosphatidyletha-
nolamine (Geng and Klionsky, 2008). Atg7 is a necessary cata-
lyst in both conjugation systems and is therefore essential for 
autophagy (Tanida et al., 1999, 2001).
Autophagy is considered a cell survival pathway that plays 
roles in development (Yue et al., 2003), immunity (Deretic 
and Levine, 2009), and cell death (Maiuri et al., 2007) and has, 
as such, been implicated in neurodegeneration, autoimmunity, 
and cancer (Levine and Kroemer, 2008). However, the role of 
autophagy in cancer remains controversial, in that it appears 
to have both tumor-promoting and -suppressive functions. 
Autophagy is induced by metabolic stress, which is com-
monly present in tumors and therefore acts as a survival factor 
for the tumor cells (White et al., 2010).
In this study, we examine the role of the essential autoph-
agy gene Atg7, which has no described autophagy-unrelated 
functions, in HSC survival and function, within the adult he-
matopoietic system. For that purpose, we conditionally de-
leted Atg7 throughout the hematopoietic system (Vav-Atg7/ 
mice; Mortensen et al., 2010a), revealing a critical cell- 
autonomous requirement for autophagy in the maintenance 
of  HSC  integrity  and  demonstrating  that  autophagy  sup-
presses myeloproliferation.
RESULTS
As homozygous knockout of Atg7 is neonatally lethal in mice 
(Komatsu et al., 2005), we conditionally deleted Atg7 in the 
hematopoietic system (Vav-Atg7/ mice).  Vav-Atg7/ mice 
develop a progressive anemia, splenomegaly, and lymphade-
nopathy and survive for a mean of only 12 wk (Mortensen   
et al., 2010a). Mechanisms underlying the progression of 
anemia over time remained unexplained. In this study, we hy-
pothesize that the lack of Atg7 in earlier stages of hematopoiesis 
could be responsible for the progressive and severe anemia 
found in Vav-Atg7/ mice. Cell-intrinsic defects caused 
by the absence of mitochondrial autophagy (mitophagy) 
were found to cause both the lymphopenia and anemia of   
repopulation assay. CD45.2+ BM cells from WT (left) or Vav-Atg7/ (right) 9-wk-old mice were mixed 1:1 with CD45.1+ WT competitor BM cells and 
transplanted into lethally irradiated CD45.1+ WT recipients (n = 6 per group). Representative dot plots illustrating the CD45.2+ population frequency of 
donor-derived cells in peripheral blood of the recipient mice 16 wk after transplantation are shown. (E) Mean percentage (±SEM) of donor-derived 
CD45.2+ cells in peripheral blood of CD45.1+ recipients (n = 6 per group) described in D analyzed at 4, 12, and 16 wk after transplantation. (F) Lethally 
irradiated recipients were transplanted with 2 × 106 WT BM cells alone (n = 3), Vav-Atg7/ BM cells (1.8 × 106 cells) in a 10:1 ratio with CD45.1+ com-
petitor BM (0.2 × 106 cells; n = 4), or 2 × 106 Vav-Atg7/ BM cells alone (n = 4). The mean percentage (±SEM) of CD45.2+ cells (gated as shown in D) in 
peripheral blood of the recipient mice is shown. Analysis was performed 4, 8, and 12 wk after transplantation. § indicates that recipients of Vav-Atg7/ 
BM cells alone had to be culled 4 wk after transplantation because of poor health, and no further analysis could therefore be performed. (G) Kaplan-Meier 
survival curves of recipient mice of the in vivo reconstitution assays described in F. (H) Kaplan-Meier survival curves of lethally irradiated recipients of 
either 104 WT or Vav-Atg7/ flow-sorted BM LSK cells. (I) Lethally irradiated recipients were transplanted with 2 × 106 WT (n = 5) or Vav-Atg7/ (n = 6) 
FL cells. The mean percentage (±SEM) of CD45.2+ donor cells in peripheral blood of the recipient mice over time is shown. The percentages of CD45.2+ 
myeloid (CD11b+Gr1+), B (B220+CD19+), and T cells (CD4+ and CD8+) are indicated (populations gated as shown in Fig. S1 F). Four out of six of the Vav-
Atg7/ FL recipients had to be culled 7 wk after transplant because of their poor state. However, for simplicity, their percent blood populations are 
shown combined with those of the remaining recipient mice, which were bled 8 wk after transplantation. Two-tailed Mann-Whitney tests were performed 
on the indicated datasets (ns, nonsignificant; **, P < 0.01). (J) Kaplan-Meier survival curves of the lethally irradiated FL transplant recipients from I.
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sacrificed. These mice developed symptoms reminiscent of 
those developed by adult Vav-Atg7/ mice, despite the ap-
parent hematopoietic reconstitution (Fig. 1 I and Fig. S1 F). 
Importantly, although Vav-Atg7/ FL cells were able to en-
graft and produce mature lymphoid and myeloid cells, the 
percentage of donor CD45.2+ cells was significantly lower in 
all  Vav-Atg7/ FL chimeras compared with the WT FL ones 
(Fig. 1 I and Fig. S1 F). This suggests that, although hemato-
poietic reconstitution can be achieved by transplanting Vav-
Atg7/  FL  cells,  Atg7-deficient  FL  HSC  functions  are 
impaired relative to WT FL HSCs. Collectively, these data in-
dicate that the requirement of Atg7 is essential for adult HSC 
maintenance and is less critical for fetal HSC functions.
Hematopoietic stem and progenitors of multiple lineages 
are severely reduced in the absence of Atg7
To investigate the defective in vivo reconstitution capacity of 
Vav-Atg7/ HSCs, we performed immunophenotypic analy-
sis of the HSPC compartment of Vav-Atg7/ mice. Al-
though the overall BM cell count was significantly reduced in 
Vav-Atg7/ mice (Fig. 2 A), we found the absolute numbers 
of LSK cells significantly increased in asymptomatic 7-wk-old 
Vav-Atg7/ mice (Fig. 2 C), whereas the LinSca-1c-Kit+ 
(LK) compartment, containing more mature hematopoietic 
progenitors, was significantly decreased (Fig. 2 D). However, 
although the expansion of the LSK compartment was charac-
teristic of all asymptomatic Vav-Atg7/ mice, as they devel-
oped symptoms with age (from 7 wk onwards), the frequency 
of LSK cells fell to WT levels (Fig. 2 B). The numbers of 
HSCs, defined as LSK CD48CD150+ (Kiel et al., 2005), 
were then investigated in the BM of WT and Vav-Atg7/ 
mice (Fig. 2, E and F). These were found to be significantly 
reduced in all Vav-Atg7/ mice, regardless of their disease 
progression (Fig. 2 F), corroborating the observed inability of 
Vav-Atg7/ BM cells to repopulate lethally irradiated recip-
ients. This suggests that the observed LSK cell expansion is 
not attributable to an increase of HSC numbers.
To investigate the production of downstream progenitors 
in an Atg7-deficient BM, we then characterized common 
lymphoid progenitors (CLPs), NK cell progenitors (NKPs), 
and the myeloid progenitor compartment. CLPs, defined as 
LinFlt3HighIL7RaHighSca-1Lowc-KitLow (Kondo et al., 1997), 
were  found  significantly  reduced  in Vav-Atg7/  mice 
(Fig. 3, A and B). Interestingly, although the absolute numbers 
of BM LinFlt3HighIL7RaHigh cells are significantly reduced in 
Vav-Atg7/ mice, these cells are mostly Sca-1+c-KitLow and 
are therefore different from the classically defined CLPs. The 
numbers of CCR9+ LMPPs (Benz and Bleul, 2005; Svensson 
et al., 2008) were also investigated (Fig. 3, C and D) and found 
significantly reduced in the BM of Vav-Atg7/ mice. Al-
though no difference was found in numbers of NKPs (Lin 
CD3CD122+NK1.1DX5; Nozad Charoudeh et al., 2010), 
immature NK cells (LinCD3CD122+NK1.1+DX5+) were 
significantly depleted in Vav-Atg7/ BM (Fig. 3, E and F). 
The BM myeloid progenitor compartment was characterized 
using the surface markers CD150, CD41, CD105, FcgRII/III, 
overt clinical symptoms (lethargy, piloerection, and weight 
loss) by 9 wk of age (Mortensen et al., 2010a), we performed 
separate experiments using BM from either 6- (asymptom-
atic) or 9-wk-old (mostly symptomatic) mice. The peripheral 
blood of recipient mice was analyzed 4, 12, and 16 wk after 
transplantation to monitor multilineage reconstitution. As 
expected, 9-wk-old CD45.2+ WT BM cells established short- 
and long-term hematopoiesis in the lethally irradiated recipi-
ents (Fig. 1, D and E). In contrast, Atg7/ BM cells from 
9-wk-old Vav-Atg7/ mice failed to contribute to short- 
and long-term reconstitution of the lethally irradiated hosts 
(Fig.  1,  D  and  E).  Similarly,  when  6-wk-old WT  or Vav-
Atg7/ BM cells were transplanted with CD45.1+ WT BM 
into lethally irradiated hosts, Vav-Atg7/ BM cells were unable 
to establish long-term reconstitution of transplant recipi-
ents (Fig. S1, C and D). However, 6-wk-old  Vav-Atg7/ BM 
cells displayed a weak short-term reconstitution capacity (4 wk 
after transplantation) compared with their 9-wk-old counter-
part (Fig. S1 D). BM analysis of the transplant recipient mice 
revealed that Vav-Atg7/ CD45.2+ cells, including HSCs, 
were absent in the recipients 17 wk after transplantation (Fig. S1, 
B and E). In another competitive repopulation assay, when 
BM cells from WT and Vav-Atg7/ mice were transplanted 
into lethally irradiated recipients with competitor CD45.1+ 
BM cells in a 10:1 ratio, BM cells lacking Atg7 failed to con-
tribute to long-term hematopoiesis (Fig. 1 F). These experi-
ments  revealed  that  CD45.1+ WT  BM  cells  outcompete 
Vav-Atg7/ cells regardless of their initial ratios. Finally, in 
the noncompetitive experiments, Vav-Atg7/ or WT BM 
cells (CD45.2+) were transplanted without WT BM competi-
tor cells into CD45.1+ lethally irradiated hosts. All recipients 
of Vav-Atg7/ BM cells died within 4 wk after transplanta-
tion, indicating that BM cells lacking Atg7 can only sustain 
short-term hematopoiesis and, unlike WT BM cells, fail to 
rescue lethally irradiated hosts (Fig. 1, F and G). These data 
collectively indicate that Atg7 deficiency results in loss of 
HSC activity.
To test the function of Atg7/ HSCs without the con-
founding effects of the underlying anemia and lymphopenia 
of Vav-Atg7/ mice, BM LSK cells, which are enriched for 
HSCs and early progenitors, were sorted from either 8-wk-old 
WT or Vav-Atg7/ mice and transplanted into lethally   
irradiated CD45.1+ recipients. The recipients of Vav-Atg7/ 
LSK cells died within 16 d after transplantation (Fig. 1 H), in-
dicating that HSC activity is severely impaired in the absence 
of Atg7.
Zhang et al. (2009) showed that Atg7/ fetal liver (FL) 
cells can stably reconstitute lethally irradiated hosts in 50% of 
cases. To understand the differential roles of Atg7 in fetal and 
adult HSCs, we performed a noncompetitive reconstitution 
assay using FL cells from Vav-Atg7/ and control 14.5 d 
postimplantation  embryos  into  lethally  irradiated  recipient 
mice. Unlike adult BM cells, Vav-Atg7/ FL cells stably re-
constituted the hematopoietic system of lethally irradiated 
recipients in 30% of cases (Fig. 1 J). However, 70% of the 
Vav-Atg7/ FL recipient mice became moribund and were JEM VOL. 208, March 14, 2011 
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a similar mechanism could explain the increase followed by 
depletion of the Atg7/ LSK compartment. LSK cells were 
therefore stained with MitoTracker green (an indicator of   
mitochondrial  mass),  MitoTracker  red  (membrane  potential– 
dependent mitochondrial dye), and MitoSOX (mitochondrial 
superoxide–sensitive fluorophore). This showed that LSK cells 
from Vav-Atg7/ BM accumulate mitochondria with a 
higher membrane potential and display increased mitochon-
drial superoxide production (Fig. 4, A–C) compared with WT 
LSK cells.
As the accumulation of ROS can cause DNA damage, we 
assessed levels of DNA damage in LSK cells by staining with 
anti-53BP1  (anti–p53  binding  protein  1)  antibody.  53BP1 
translocates to the nucleus to form foci around sites of DNA 
strand breaks (Ward et al., 2003). The formation of increased 
and Ter119, as described in Pronk et al. (2007; Fig. 3 G).   
A  significant  reduction  in  most  myeloid  progenitors  was 
found (Fig. 3 H), which is consistent with the reduced LK 
compartment of Vav-Atg7/ BM. Thus, Vav-Atg7/ mice 
have reductions in progenitors of multiple lineages, in keep-
ing with their loss of HSCs.
Atg7/ LSK cells accumulate mitochondria, mitochondrial 
superoxide, and DNA damage and display higher levels  
of apoptosis and proliferation
We previously demonstrated that RBCs and T lymphocytes 
from Vav-Atg7/ mice are highly susceptible to cell death 
caused by an accumulation of mitochondria and mitochon-
drial superoxide in the absence of Atg7-mediated mitophagy 
(Mortensen et al., 2010a). We therefore investigated whether 
Figure 2.  HSCs are absent in the BM of Vav-Atg7/ mice. (A) Total BM cell counts from 6- and 9-wk-old WT (Vav-iCre+; Atg7Flox/WT or Vav-iCre; 
Atg7Flox/Flox; n = 4) and Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox; n = 4) mice. Data are presented as means ± SEM (*, P < 0.05, Mann-Whitney test). (B) Repre-
sentative dot plots of WT and Vav-Atg7/ LK and LSK compartments, gated on Lin BM cells. The LK and LSK cell frequencies within the Lin population 
are shown. (C) Total BM LSK cell counts from 7-wk-old WT (n = 5) and Vav-Atg7/ (n = 6) mice. LSK cells were gated as shown in B (**, P = 0.0043, 
Mann-Whitney test). (D) Total BM LK cell counts from 7-wk-old WT (n = 5) and Vav-Atg7/ (n = 6) mice. LK cells were gated as shown in B (**, P = 0.0087, 
Mann-Whitney test). Results in A–D are representative of at least six independent experiments. (E) Absolute HSC (LSK CD150+CD48) counts in the  
BM of WT and Vav-Atg7/ mice determined by gating as shown in F (**, P = 0.002, Mann-Whitney test). (C–E) Horizontal bars indicate the mean.  
(F) HSC immunophenotyping in the BM of 7-wk-old WT and Vav-Atg7/ mice. Dot plots are representative of n = 6 mice in each genotype and of three 
independent experiments. For each genotype, left plots are gated on Lin cells, and right plots are gated on Sca-1+c-Kit+ (LSK) cells. The numbers in the 
dot plots indicate the percentage within the corresponding parent population.460 Adult HSCs require autophagy | Mortensen et al.JEM VOL. 208, March 14, 2011 
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We next examined the frequencies of CD11b+Gr1+ cells 
in the spleen and BM of WT and Vav-Atg7/ mice and 
found that they were increased in both organs of  Vav-Atg7/ 
mice (Fig. 6 B and not depicted). Consistent with this, stain-
ing for the proliferation marker Ki67 showed higher prolif-
erative rates among Vav-Atg7/ CD11b+Gr1+ cells relative 
to their WT counterparts (Fig. 6 C). We also investigated the 
presence  of  myeloproliferative  infiltrates  in  hematopoietic 
and nonhematopoietic tissues by histology. These experi-
ments revealed the presence of atypical myeloid infiltrates in 
a wide range of organs in all Vav-Atg7/ mice examined, as 
well as a peripancreatic cell mass in one symptomatic Vav-
Atg7/ mouse (Fig. S2, A–H and Tables S1 and S2). To con-
firm the myeloid origin of the infiltrating cells, we performed 
immunohistological analyses and found that infiltrating cells 
expressed myelomonocytic markers CD68 and CD11b (Fig. S2, 
I and J) but did not express markers specific for other hema-
topoietic lineages. Furthermore, we found the expression of 
Ki67 in 30–80% of the infiltrating cells’ nuclei in lymph 
nodes, indicating high proliferation rates of these cells (Fig. S2 L). 
These data, together with up-regulation of CD47 (a marker 
of myeloid leukemias) on myeloid cells from the blood 
(Fig. S3, A and B) and BM (Fig. S3 C) of Vav-Atg7/ mice 
(Jaiswal et al., 2009), suggest that loss of autophagy in HSCs 
leads to a potentially malignant myeloproliferative disorder 
(MPD) in mice.
We next examined whether the myeloproliferation in 
Vav-Atg7/ mice could be recapitulated in transplanted 
animals. Indeed, atypical myeloproliferation could be found 
in hematopoietic and nonhematopoietic organs of suble-
thally irradiated Rag-1 knockout mice transplanted with 
BM cells from Vav-Atg7/ (Table S3). The myeloprolifera-
tion from Vav-Atg7/ mice was also transplanted during 
the noncompetitive BM repopulation assay described in   
Fig. 1 (F and G) and Table S3. Moreover, when transplanting 
FL cells from Vav-Atg7/ mice, the FL recipients having 
developed symptoms 7 wk after transplant were found posi-
tive for myeloid infiltrates at peripheral sites, and in two out 
of four of the symptomatic mice, myeloid proliferation had 
also settled in the BM (Table S3). Finally, infiltrating my-
eloid cells were also found in the peripheral hematopoietic 
organs of the lethally irradiated recipients of Vav-Atg7/ 
LSK cells, suggesting that this atypical myeloproliferation 
arises from LSK cells.
numbers of foci, as seen with transformed cells, indicates more 
DNA damage and can be detected as higher fluorescence by 
flow cytometry using anti-53BP1. The LSK compartment of 
7-wk-old  Vav-Atg7/ showed increased 53BP1 fluorescence 
compared with WT (Fig. 4 D), indicating that the absence of 
Atg7 in the hematopoietic system results in the accumulation 
of DNA damage in LSK cells.
We then investigated whether the progressive loss of LSK 
cells in Vav-Atg7/ mice could be caused by increased cell 
death  in  this  compartment. A  higher  proportion  of Vav-
Atg7/ BM LSK cells contained active caspase 3 (Fig. 4 E), 
suggesting that Atg7/ LSK cells are more prone to apopto-
sis. Next, we determined the proliferation status of WT and 
Atg7/ LSK cells by staining for Ki67 and found that   
Vav-Atg7/ cells within the LSK compartment displayed   
increased proliferation compared with WT cells (Fig. 4 F). 
Collectively, these results indicate that the progressive loss of 
LSK cells lacking Atg7 may be attributed, at least in part, to 
their defective survival.
Vav-Atg7/ mice show atypical myeloproliferation
Having established that HSPCs are decreased in Vav-Atg7/ 
mice, it was important to determine whether all hematopoi-
etic lineages were similarly affected by the absence of Atg7. 
We therefore determined the absolute numbers of lymphoid 
(TCR-+ T cells, CD19+ B cells, and NK.1.1+ NK cells) and 
myeloid cells (CD11b+Gr1, CD11bGr1+, and CD11b+Gr1+ 
cells) in the blood of WT and  Vav-Atg7/ mice at 5, 6, 7, and 
8 wk of age (Fig. 5, A–F). The absolute cell counts of T, B, and 
NK cells were all significantly decreased in the peripheral 
blood of Vav-Atg7/ mice at all time points examined (Fig. 5, 
A–C). Moreover, the numbers of T, B, and NK cells dropped 
steadily over time. Similarly, the numbers of the myeloid sub-
sets CD11b+Gr1 and CD11bGr1+ (Fig. 5, D and E) were 
significantly reduced in the blood of Vav-Atg7/ mice at all 
ages studied and decreased further over time. In contrast, the 
numbers of CD11b+Gr1+ cells were significantly increased in 
the blood of  Vav-Atg7/ mice aged 5 and 6 wk but then de-
creased to below WT levels in 8-wk-old Vav-Atg7/ (Fig. 5 F 
and Fig. 6 A). These results indicate that defective HSC main-
tenance translates into multilineage cytopenias in  Vav-Atg7/ 
mice, which worsen over time. The progression of the cyto-
penias could be a secondary effect of gradual BM failure in 
the late stages of disease.
Figure 3.  Hematopoietic progenitors of multiple lineages are reduced in the BM of Vav-Atg7/ mice. BM cells from WT (Vav-iCre+; Atg7Flox/WT 
or Vav-iCre; Atg7Flox/Flox) and Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox) mice were stained with the indicated antibodies and analyzed by flow cytometry.  
(A) CLPs were identified as Sca-1Lowc-KitLow cells within LinFlt3HighIL7RaHigh cells. (B) Absolute BM CLP counts were determined by gating as shown in A. 
(C) CCR9+ LMPPs were identified as Flt3HighCCR9+ cells within LSK cells. (D) Absolute CCR9+ LMPPs counts were determined by gating as shown in C.  
(E) NKPs were identified as NK1.1DX5 cells within LinCD3CD122+ cells, and immature NK cells were identified as NK1.1+DX5+ cells within 
LinCD3CD122+ cells. (F) Absolute BM NKP and immature NK cell counts were determined by gating as shown in E. Representative plots of WT (left) and 
Vav-Atg7/ (right) BM are shown in A, C, and E. (B, D, and F) Horizontal bars indicate the mean (**, P < 0.01; ns, nonsignificant). (G) The LK myeloid pro-
genitor compartment was immunophenotyped as described in Pronk et al. (2007). The gating strategies applied are shown for WT (top) and Vav-Atg7/ 
BM (bottom). CFU-E, CFU erythroid; GMP, granulocyte-macrophage progenitor; MkP, megakaryocyte progenitor. (H) Absolute cell counts of BM myeloid 
progenitors were determined by gating as shown in G. The numbers in dot plots indicate the percentage within the corresponding parent population. 
Error bars indicate SEM (**, P < 0.01; ns, nonsignificant from Mann-Whitney tests).
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overall LSK compartment is expanded, resulting in enhanced 
myeloproliferation in Vav-Atg7/ mice. Although lack of 
autophagy results in a cell-autonomous defect in LSK cells, 
the severe myeloproliferation taking place in Vav-Atg7/ 
mice is likely to exacerbate the HSPC phenotype. Together, 
our data provide genetic evidence that autophagy is essential 
for the maintenance of HSCs.
Hypoxia, mitophagy, and oxidative stress  
in HSC maintenance
Normal quiescent HSCs are maintained in hypoxic niches, 
providing the optimal microenvironment to sustain their func-
tions (Takubo et al., 2010). Moreover, autophagy is an adaptive 
prosurvival pathway in response to hypoxic conditions (Semenza, 
2010). Consistent with this, our study demonstrated that loss 
of autophagy in the HSPC compartment results in loss of 
LSK CD150+CD48 HSCs. We therefore propose that the 
hypoxic stem cell niche microenvironment may promote   
autophagy in HSCs to sustain their life-long integrity.
Recent evidence indicates that the tight regulation of mito-
chondrial  homeostasis  is  essential  for  adult  HSC  integrity 
(Gan et al., 2010; Gurumurthy et al., 2010; Nakada et al., 
2010). Indeed, normal HSCs have relatively few mitochon-
dria, and increased mitochondrial biogenesis has been dem-
onstrated to trigger defective HSC maintenance (Kim et al., 
1998; Chen et al., 2008). We show that Atg7-deficient LSK 
cells accumulate mitochondria with high membrane poten-
tial, suggesting that mitophagy is an important mechanism for 
the regulation of mitochondrial quantity and quality in this 
compartment. More importantly, the lack of mitochondrial 
quality control in the absence of Atg7 leads to the accumula-
tion of mitochondrial superoxide. The TSC (tuberous scle-
rosis complex)–mTOR (mammalian target of rapamycin) 
pathway  has  been  shown  to  maintain  the  quiescence  and 
function of HSCs by repressing ROS production (Chen et al., 
2008), which our data suggest may occur through induction 
of mitophagy.
ROS are thought to play a role in carcinogenesis and age-
ing (Balaban et al., 2005). Not surprisingly, mice lacking the 
antioxidant enzyme Prdx1 have a shortened lifespan, suffer 
from hemolytic anemia, and develop hematological malig-
nancies (Neumann et al., 2003). The similarities between the 
Prdx1/ and Vav-Atg7/ phenotypes highlight ROS as an 
important underlying cause of the anemia and the develop-
ment of destructive atypical myeloproliferation in Vav-Atg7/ 
mice. It is also interesting to note that compared with murine 
models deficient for PTEN (phosphatase and tensin homo-
logue) or with constitutively active AKT (Kharas et al., 2010), 
which, besides the loss of HSCs, display both myeloid and 
lymphoid proliferation, the atypical infiltrates and prolifera-
tion in Vav-Atg7/ mice are restricted to the myeloid lin-
eage. It is known that common myeloid progenitors (CMPs) 
produce significantly higher levels of ROS than other HSPCs 
(Tothova et al., 2007). Moreover, a study of Drosophila melano-
gaster CMPs showed that the higher ROS levels in these are 
required for normal myeloid differentiation, whereas increasing 
DISCUSSION
By using a conditional knockout of Atg7 in the hematopoi-
etic system, we demonstrate that autophagy-deficient LSK 
cells accumulate aberrant mitochondria, generate increased 
levels of ROS, and show excessive DNA damage, leading to 
dramatic changes in HSC integrity. A severe loss of HSCs re-
sults from the lack of functional autophagy, which is reflected 
in a significant reduction in progenitors of multiple lineages 
leading to multilineage cytopenias and BM failure. Although 
rare HSCs within the LSK compartment are reduced, the 
Figure 4.  LSK cells from Vav-Atg7/ mice accumulate mitochon-
dria, mitochondrial superoxide, and DNA damage and display in-
creased apoptosis and proliferation. (A–F) LSK cells from WT (Vav-iCre+; 
Atg7Flox/WT or Vav-iCre; Atg7Flox/Flox) and Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox) 
mice were stained with MitoTracker green (MTG; A), MitoTracker red  
(MTR; B), MitoSOX (C), 53BP1 (D), active caspase 3 (E), and Ki67 (F).  
A–C represent BM cells from 9-wk-old WT (n = 4) and Vav-Atg7/ (n = 4) 
mice. D and F represent BM cells from 7-wk-old WT (n = 2) and Vav-
Atg7/ (n = 2) mice. In E, BM from 6-wk-old WT (n = 5) and Vav-Atg7/ 
(n = 3) mice was analyzed. *, P < 0.05 from Mann-Whitney tests on the 
fluorescence geometric mean of the indicated dye/antibody. Autofluores-
cence levels were confirmed to be similar in WT and Vav-Atg7/ cells 
using unstained, single stained, and fluorescence minus one controls on 
both cell types.JEM VOL. 208, March 14, 2011 
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FIP200 (mammalian counterpart of yeast Atg17) knockout 
mice found that FIP200-deficient FL HSCs are lost and the 
mice develop anemia and die perinatally (Liu et al., 2010).   
A myeloproliferation was also found to result from lack of 
FIP200 in FL HSCs; however, myeloid neoplasms were not 
described. Moreover, in competitive repopulation assays, 
FIP200-deficient FL HSCs were outcompeted by WT HSCs. 
It could be envisaged that Atg7/ FL cells may also become 
outcompeted  in  competitive  repopulation  assays. Alterna-
tively, the effect of FIP200 deficiency on FL cells may be 
caused by its autophagy-independent roles.
Autophagy in myeloid proliferation and malignancy
The infiltrating myeloid cells seen in Vav-Atg7/ mice re-
semble human acute myeloid leukemia histologically. One 
could therefore hypothesize that the symptoms and death of 
Vav-Atg7/ mice are caused by the development of myeloid 
malignancies. Although further studies will be required to 
substantiate this hypothesis, the following findings support 
the diagnosis of myeloid malignancies in Vav-Atg7/ mice 
(Kogan et al., 2002): (a) the cells infiltrating nonhematopoi-
etic and hematopoietic organs are atypical and blast-like, 
(b) most animals had >20% myeloid blasts in the BM, and 
(c) the myeloproliferation can be transplanted to recipients of 
ROS above their basal levels triggers precocious differentia-
tion (Owusu-Ansah and Banerjee, 2009). We would therefore 
like to propose that the selective myeloid involvement seen in 
Vav-Atg7/ mice is caused by, on the one hand, the extreme 
susceptibility to cell death of  Atg7/ lymphocytes (Mortensen 
et al., 2010a) and, on the other hand, by the fact that increased 
ROS bias CMPs toward myeloid differentiation. The specific 
requirement of Atg7 for the survival of lymphoid cells could 
indeed explain why no lymphoid proliferation arises in our 
model, as opposed to the PTEN or AKT models. Finally, the 
myeloid restriction of the proliferative disease in Vav-Atg7/ 
mice may also be caused by an inherent resistance to ROS in 
myeloid progenitor cells enabling their survival despite high 
ROS production. Indeed, generating ROS is one of the main 
functions of terminally differentiated myeloid cells such as 
monocytes and neutrophils; a higher ROS resistance in this 
lineage could therefore be expected.
Autophagy in FL HSCs
The differential roles of Atg7 in fetal and adult HSCs are still 
unclear. Stably reconstituted autophagy-deficient FL chime-
ras have been achieved in two previous studies (Pua et al., 
2007; Zhang et al., 2009; reviewed in Mortensen et al., 2010b). 
Interestingly,  a  recent  study  of  conditional  hematopoietic 
Figure 5.  Vav-Atg7/ mice are cytopenic for all blood leukocyte populations examined except CD11b+Gr1+ cells. (A–F) The absolute periph-
eral blood counts of TCR-+ cells (A), CD19+ cells (B), NK1.1+ cells (C), CD11b+Gr1 cells (D), CD11bGr1+ cells (E), and CD11b+Gr1+ cells (F) in WT (Vav-iCre+; 
Atg7Flox/WT or Vav-iCre; Atg7Flox/Flox; n = 5) and Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox; n = 4) mice were determined at the indicated time points between the 
age of 5 and 8 wk. Error bars indicate SEM (*, P < 0.05; **, P < 0.001 from Mann-Whitney tests).464 Adult HSCs require autophagy | Mortensen et al.
lethally irradiated recipients of BM 
LSK  cells  from Vav-Atg7/  mice 
within 2 wk of transplantation, sug-
gesting that cells initiating these symp-
toms are present among LSK cells.
CD11b+Gr1+ cells were found increased in the blood of 
Vav-Atg7/ mice, and we show that this particular subset 
displays  higher  proliferation  rates  and  up-regulates  CD47. 
CD47 is expressed on HSPCs and leukemic cells and confers 
protection from phagocytosis by interacting with its receptor, 
SIRP-, on macrophages (Jaiswal et al., 2009). Interestingly, 
the noncompetitive transplantation of Vav-Atg7/ BM cells 
into either immunocompromised or lethally irradiated re-
cipients  led  to  myeloid  infiltrates  only  at  peripheral  sites 
without BM involvement. However, BM involvement could 
be found in recipients of Vav-Atg7/ FL. This could suggest 
that because the HSPCs from adult Vav-Atg7/ mice have 
lost their repopulation ability, the atypical myeloid cells within 
that compartment have equally lost the ability to invade the 
BM. In contrast, the HSPCs of FL origin still able to recon-
stitute lethally irradiated mice can also form myeloprolifera-
tive foci in the BM.
Relevance to human MPD and myelodysplastic  
syndrome (MDS)
Based on our findings and on reports that autophagy levels 
decrease with age (Cuervo, 2008), we propose that failure to 
remove mitochondria, leading to the accumulation of DNA 
mutations in HSPCs, may account for the increased incidence 
of MPD/MDS in older patients. The accumulation of mito-
chondrial iron deposits in ringed sideroblasts has indeed been 
suggested as evidence of mitochondrial dysfunction in MDS 
(Fontenay et al., 2006). It was also recently found that ery-
throid precursors from high risk MDS patients (those likely 
to progress to leukemia) have lower autophagy levels com-
pared with low risk MDS patients, highlighting a role for mi-
tophagy in the progression of MDS to leukemia (Houwerzijl 
et al., 2009). Vav-Atg7/ mice therefore represent a novel 
Atg7/ BM, FL, or LSK cells. Autophagy may indeed func-
tion as a protective mechanism against leukemogenesis. Inter-
estingly Beclin 1 (Atg6) is monoallelically deleted in some 
cancers (Aita et al., 1999; Liang et al., 1999), implying that 
autophagy  may  be  protective  against  tumor  formation.  In 
mouse models, autophagy has also been shown to suppress 
tumors  by  preventing  the  accumulation  of  DNA  damage 
(Mathew et al., 2007) and p62 aggregates (Komatsu et al., 
2007; Mathew et al., 2009). Furthermore, ageing Beclin 1+/ 
mice have a significantly higher incidence of spontaneous   
tumor development (Qu et al., 2003; Yue et al., 2003) than 
age-matched WT mice.
Vav-Atg7/ LSK cells show higher ROS levels and DNA 
damage and proliferate more than normal. We hypothesize 
that high ROS levels in HSPCs may lead to genetic changes 
and could eventually confer Vav-Atg7/ HSPCs with a ma-
lignant phenotype. There is evidence that ROS-related dam-
age causes mainly smaller/point mutations (Feig et al., 1994), 
which can have a major impact on tumorigenesis (Harada   
et al., 2004). Consistent with our hypothesis, we failed to 
identify copy number variations of large genomic regions in 
the increased CD11b+Gr1+ population in Vav-Atg7/ mice 
by array comparative genomic hybridization and karyotyping 
analyses (unpublished data). Yet, we found small regions with 
copy number variations encompassing a few genes with links 
to leukemia (unpublished data).
The atypical myeloid proliferation in Vav-Atg7/ mice   
is likely to arise from an HSPC, as mice with LysM-Cre– 
mediated deletion of Atg7 in myeloid progenitors and myeloid 
cells (Clausen et al., 1999; Ye et al., 2003) survived normally 
and showed no signs of myeloid proliferation at autopsy 
(unpublished data). Moreover, despite the lack of hematopoi-
etic repopulation, atypical myeloid cells were found in the 
Figure 6.  CD11b+Gr1+ cells accumulate 
in the blood and BM of Vav-Atg7/ and 
express higher levels of the proliferation 
marker Ki67. (A) Peripheral blood cells from 
7-wk-old WT and asymptomatic Vav-Atg7/ 
mice were stained with antibodies specific for 
CD11b and Gr1. (B) Representative CD11b and 
Gr1 staining of 9-wk-old WT (Vav-iCre+;  
Atg7Flox/WT or Vav-iCre; Atg7Flox/Flox) and asymp-
tomatic Vav-Atg7/ (Vav-iCre+; Atg7Flox/Flox) 
BM. Numbers in the dot plots indicate the 
percentage of cells within each gate. Dot plots 
are representative of at least three independent 
experiments. (C) Ki67 staining of CD11b+Gr1+ 
BM cells (gated as shown in B) from 9-wk-old 
WT (n = 5) and Vav-Atg7/ (n = 4) mice.  
*, P < 0.05 from Mann-Whitney test on the 
fluorescence geometric mean of Ki67.JEM VOL. 208, March 14, 2011 
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myeloid compartment, lineage marker staining was performed with antibodies 
against CD4, CD5, CD8a, CD11b, B220, and Gr1 (clones as above) and was 
followed by staining with Qdot605-conjugated goat anti–rat IgG (Invitro-
gen). In the CLP staining, lineage markers were stained using APC-conjugated 
anti–mouse CD3e (145-2C11), CD4, CD8a, Gr1, B220 (RA3-6B2; BD), 
and CD19 (1D3; BD). In the NKP staining, lineage markers were stained 
using  PECy5-conjugated  anti–mouse  CD4  (BD),  CD8a  (BD),  CD19 
(MB19-1), Ter119, Gr1, and CD11b. All antibodies were obtained from 
eBioscience, unless indicated otherwise.
Other  antibodies  used  for  surface  staining  were  FITC  anti–mouse 
CD11b  (M1/70),  eFluor  450  anti–mouse  CD11b  (M1/70),  FITC  anti–
mouse TCR- (H57-597), PE or Pacific blue anti–mouse NK1.1 (PK136), 
APC anti–mouse CD19, PE anti–mouse CD16/32 (93), APC anti–mouse 
Gr1 (Ly-6G), APC-eFluor 780 anti–mouse CD117 (c-Kit), FITC anti–mouse 
CD47 (miap301), PECy7 anti–mouse CD41 (MWReg30), PECy5.5 anti–
mouse Ter119, PE anti–mouse CD127 (A7R34), APC anti–mouse CCR9 
(all from eBiosciences); Pacific blue anti–mouse CD45.2 (104), Pacific blue 
anti–mouse  Sca-1  (E13-161.7),  PE  anti–mouse  CD49b  (DX5), APC  or 
PECy7  anti–mouse  CD150  (TC15-12F12.2),  biotin  anti–mouse  CD105 
(MJ7/18; BioLegend); streptavidin PETxRed, PE anti–mouse CD135 (Flt3, 
A2F10.1), FITC anti–mouse CD122 (TM-b1), and FITC anti–mouse Sca-1 
(BD). Dead cells were always excluded using either DAPI or 7AAD.
For active caspase 3 staining, cells were first surface stained, fixed and 
permeabilized (Fixation and Permeabilization kit; eBioscience), and stained 
with FITC-conjugated anti–active caspase 3 monoclonal antibody (BD). 
Alternatively, cells were fixed and permeabilized by incubation at 20°C for   
2 h in 70% ethanol before staining with PE-conjugated anti-Ki67 antibody 
(BD) or with rabbit anti-53BP1 antibody (NB100-304; Novus Biologicals), 
followed by anti–rabbit IgG and IgM Alexa Fluor 488 (Invitrogen). Mito-
chondrial stains were performed after surface marker staining by incubating 
cells at 37°C for 30 min with 100 nM MitoTracker green, 100 nM NaO,   
100 nM tetramethylrhodamine methylester, or 5 µM MitoSOX red (all from 
Invitrogen) and directly analyzed without fixing. Absolute cell numbers in 
peripheral blood were determined using TruCount tubes (BD); samples were 
then analyzed on a FACSCalibur machine (BD).
Histology, tissue staining, and immunostaining. Full autopsies were 
performed on six Vav-Atg7/ mice (one 9-wk-old male, one 10-wk-old 
male, and four 10-wk-old females), together with three WT controls (one   
9-wk-old male and two 10-wk-old females). All major organs were examined 
macroscopically, harvested, and fixed in 4% neutral buffered formalin, before 
processing to paraffin. Frozen material was retained from approximately half 
of the mice. 4-µm sections were stained with hematoxylin and eosin (H&E) 
using standard techniques. Immunostaining was performed either manually 
or using an OptiMax automated staining machine (BioGenex). Monoclonal 
rat anti–mouse primary antibodies raised against CD205 (MCA949; clone 
CC98), CD3 (MCA500G), CD19 (MCA1439), c-kit (2B8), polyclonal rab-
bit anti–Pax-5 (Abnova), Ly6G/Gr1 (RB6-8C5; eBioscience), and polyclonal 
rabbit anti-ankyrin (Abcam) were used on frozen sections, with WT mouse 
lymph node as a positive control. Monoclonal rat anti–mouse CD45R (B220; 
R&D  Systems)  and  polyclonal  rabbit  anti–mouse/human  CD3  (A0452; 
Dako) were used on formalin-fixed, paraffin-embedded sections, with WT 
mouse lymph node as a positive control.
Monoclonal rat anti–mouse primary antibodies raised against CD68 
(MCA1957; AbD Serotec), CD11b (M1/70), and polyclonal rabbit anti–
mouse serum raised against myeloperoxidase (Ab45977; Abcam) were used 
on frozen sections, with WT mouse lymph node as a positive control. VEC-
TASTAIN ABC kits against rat or rabbit or the VECTASTAIN mouse on 
mouse immunodetection kit (Vector Laboratories) was used for primary 
antibody detection. Slides were counterstained with Mayer’s hematoxylin 
and mounted in DePex mounting medium (VWR International). Sections 
were examined by a specialist hematopathologist and photographed with a 
camera (DS-FI1; Nikon) with a control unit (DS-L2; Nikon) and a micro-
scope (BX40; Olympus). Finally, BM smears were performed by smearing 
onto a slide 5 µl of BM suspension obtained by crushing tibias and femurs 
model for hematopoietic defects, which could be particularly 
beneficial for understanding the importance of mitochondrial 
quality control in the prevention of these diseases.
In conclusion, we provide genetic evidence that Atg7 is an 
essential regulator of adult HSC maintenance. We propose 
that quiescent HSCs require the efficient process of autophagy, 
which controls mitochondrial mass, ROS levels, and genomic 
integrity, to maintain normal HSC functions and sustain mul-
tilineage hematopoiesis. The relationship between autophagy 
and leukemic transformation remains an open question mer-
iting future investigation.
MATERIALS AND METHODS
Mice. Mice were bred and housed in the Department of Biomedical Ser-
vices, University of Oxford in individually ventilated cages. Atg7Flox/Flox mice 
were crossed to Vav-iCre mice (from D. Kioussis, Medical Research Council 
National Institute for Medical Research, London, England, UK) to obtain 
Vav-iCre; Atg7Flox/Flox. Genotyping was performed on ear genomic DNA as 
described previously (de Boer et al., 2003; Komatsu et al., 2005). Male and 
female mice were used equally in all experiments.  Vav-iCre; Atg7Flox/Flox and 
Vav-iCre+; Atg7Flox/WT littermates were used equally as littermate controls.   
All animal experiments were approved by the local ethical review committee 
and performed under a Home Office license.
Quantitative  PCR  (Q-PCR). RNA extraction and Q-PCR reactions 
were performed as previously described (Kranc et al., 2009). All experiments 
were performed in triplicate. Differences in input cDNA were normalized 
with a combination of Gapdh and Ubc expression.
CFC assays. MethoCult GF M3434 medium (STEMCELL Technologies 
Inc.) was used to enumerate mouse CFCs. Three replicates were used per 
group in each experiment. Colonies were tallied at days 10–14.
In vivo transplantation experiments. In competitive in vivo repopula-
tion assays, CD45.1+ competitor BM cells were mixed with CD45.2+ test 
donor BM cells in a 1:1 or 1:10 ratio, whereas in noncompetitive repopula-
tion assays, only CD45.2+ cells were transplanted into CD45.1+ lethally irra-
diated hosts. The competitor cell numbers for each experiment are stated in 
Table S1. Overall, 2 × 106 total BM cells, 2 × 106 FL cells, or 104 sorted LSK 
cells  were  injected  intravenously  into  lethally  irradiated  (9  Gy)  B6SJL 
CD45.1+ recipients. FL cells (CD45.2+) were obtained from 14.5 d post-
implantation embryos. LSK cell BM and FL transplant recipients were bled 4, 
8, 12, and 16 wk after transplantation, and multilineage reconstitution was 
monitored in peripheral blood. In the leukemia transplantation experiment, 
2 × 106 BM cells were injected intravenously into sublethally irradiated (4.5 Gy) 
Rag-1/ hosts. All transplantation experiments were terminated according 
to UK Home Office regulations.
Determination of total BM counts. Tibias and femurs of both hind 
legs were taken from each mouse. These were crushed using a pestle and   
mortar, and a BM suspension was obtained. The nucleated cells within 
each suspension were then counted by the Trypan blue dye exclusion test of 
cell viability.
Flow cytometry. Flow cytometry experiments were performed on CyAn 
or LSRII instruments (Dako), unless otherwise stated, and data were analyzed 
with FlowJo 9.1 for Mac (Tree Star, Inc.). Single cell suspensions from BM, 
spleen, and peripheral blood were surface stained with the indicated antibodies. 
In most cases, Lin markers were stained using unconjugated rat anti–mouse 
CD4  (RM4-5),  CD5  (53–7.3)  CD8a  (53–6.7),  CD11b  (M1/70),  B220 
(CD45R), Ter119 (TER-119), and Gr1 (RB6-8C5), followed by staining 
with Cy5–R-PE–conjugated goat anti–rat IgG (Invitrogen). The same anti-
body clones were used for all lineage marker stainings. For staining of the BM 466 Adult HSCs require autophagy | Mortensen et al.
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